Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2016 Financial Results on March 1, 2017
February 16 2017 - 6:00AM
Business Wire
Eagle Pharmaceuticals, Inc. ("Eagle" or “the Company”) (Nasdaq:
EGRX) announced today that the Company will release its 2016 fourth
quarter and full year financial results on Wednesday, March 1,
2017, before the market opens.
Scott Tarriff, Chief Executive Officer, David Pernock, President
and Chief Commercial Officer, and David E. Riggs, Chief Financial
Officer, will host a conference call to discuss the results as
follows:
Date Wednesday, March 1, 2017 Time 8:30 A.M.
EST Toll free (U.S.) 888-632-3384 International 785-424-1675
Webcast (live and replay)
www.eagleus.com, under the “Investor
Relations” section
A replay of the conference call will be available for one week
after the call's completion by dialing 800-839-1320 (US) or
402-220-0488 (International) and entering conference call ID
EGRXQ416. The webcast will be archived for 30 days at the
aforementioned URL.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
company’s website at www.eagleus.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170216005339/en/
Investor Relations for Eagle Pharmaceuticals, Inc:Lisa M.
Wilson, 212-452-2793
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From May 2023 to May 2024